Fundraising Fox

Pappas Capital

Venture capital

Research Triangle Park · Seed–Late Stage · 15 people tracked

Also known as A.M. Pappas & Associates, LLC · PAPPAS CAPITAL, LLC

Fox Verdict
Sign up to see your fit

Investment thesis

Pappas Capital focuses on the life sciences, investing in and building innovative companies that develop next-generation life science products and technologies. Over more than three decades it has backed over 100 companies across the United States, Canada, and Asia, spanning the full range of human disease. Its portfolio companies have brought to market products treating conditions such as melanoma, ovarian cancer, and hemophilia, which have been used worldwide to treat tens of thousands of patients and generated billions of dollars in revenue. The firm offers both capital and operational expertise to founders building life science businesses.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
Check
$100K – $6M
HQ
Research Triangle Park, North Carolina, US
Instruments
Equity
Founded
1994
AUM
$800M
VC funds
8
Tracked investments
5

Team · 15 people

from curated & public directories

What they invest in

from 5 of 5 portfolio companies

Biotech ×4Healthtech ×3Cloud Computing ×1Consumer ×1Media & Entertainment ×1Sports Tech ×1

HQs:United States×1Vietnam×1

Investments · 5 tracked

founders shown can be your intro path
Curasencurasen.com✓ verified

CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.

BiotechHealthtech

Anthony Fordin

Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupJohnson & Johnson Innovation – JJDCNew Leaf Venture Partners+2 more

Reneo Pharmaceuticalsreneopharma.com

Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.

ConsumerMedia & EntertainmentSports Tech

Co-investorsAisling CapitalNew Enterprise Associates (NEA)AbingworthLundbeckfonden VenturesRiverVest Venture Partners

Ribometrixribometrix.com

BiotechGreenville, US

Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)

BoardMike Dial(Director)in

Co-investorsIllumina VenturesM VenturesMC Healthcare VenturesPappas CapitalSV Health InvestorsDementia Discovery Fund+1 more

Solusolu.bioin𝕏

Solu provides a cloud-based genomic surveillance platform that analyzes microbial genomes in real-time without requiring coding or configuration.

BiotechCloud ComputingHealthtech

Co-investorsLifeline VenturesWave Ventures

Solusolutherapeutics.comin𝕏

Solu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels.

BiotechHealthtech

Phil Vickers(CEO / Leadership)Michael Boretti(Leadership)Brandon Turunen(Leadership)Sergio Santillana(Leadership)Enda Moran(Leadership)Kelly Honohan(Leadership)

Co-investorsAstellas Venture Management LLCLongwood Fund

Portfolio news

latest coverage across their companies
Sell or Invest in Curasen Stock Pre-IPO

Curasen · nasdaqprivatemarket.com · Mar 2, 2025

Public market activity · per SEC filings

what is this? ⓘ
SC 13D/A filingSC 13D/A

Disclosed stake · filed Feb 2016

view filing ↗
SC 13G/A filingSC 13G/A

Disclosed stake · filed Feb 2016

view filing ↗
SC 13D filingSC 13D

Disclosed stake · filed Feb 2016

view filing ↗
SC 13G/A filingSC 13G/A

Disclosed stake · filed Feb 2015

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Mar 2014

view filing ↗
SC 13G/A filingSC 13G/A

Disclosed stake · filed Feb 2014

view filing ↗
SC 13G filingSC 13G

Disclosed stake · filed Nov 2012

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Jul 2011

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed May 2011

view filing ↗
SC 13D filingSC 13D

Disclosed stake · filed Aug 2010

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Mar 2006

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Dec 2005

view filing ↗

14 insider ownership filings (Forms 3/4/5)

From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.

Frequently asked questions

What stage does Pappas Capital invest at?
Pappas Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
What is Pappas Capital's typical check size?
Pappas Capital typically writes checks of $100K – $6M.
What sectors does Pappas Capital focus on?
Pappas Capital focuses on Biotech, Healthtech, Medical Devices.
Where is Pappas Capital located?
Pappas Capital is headquartered in Research Triangle Park, US.

Images

Pappas Capital photo

Co-investors · 6

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

Both backed · 1
$200K – $40M
Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M
Canaan Partners

Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.

$500K – $20M
EQT Life Sciences

EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.

$11M – $66M
Avoro Capital Advisors

Avoro Capital Advisors is an investment firm focused on healthcare and life sciences, pursuing scientific breakthroughs that address unmet medical needs.

Amplitude Venture Capital

Amplitude Venture Capital is a Canadian venture firm that creates, builds, and grows precision medicine companies aimed at improving patient outcomes.

Firms observed investing alongside Pappas Capital, from public investor directories. Shared companies are the overlap with Pappas Capital's recorded portfolio.

Similar investors

Featured in lists